Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis is a research paper published in JCI Insight (2020). On theSindex it has a DataRank of 0. It has been cited 48 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI110557
NINDS NIH HHS
Grant: R01 NS080821
NIAID NIH HHS
Grant: UM1 AI144298
NIAID NIH HHS
Grant: R03 AI105029
NICHD NIH HHS
Grant: T32 HD007505
NIAID NIH HHS
Grant: R21 AI115117
National Institutes of Health
Grant: 1R21AI115117-01
B Cell Exosome and Nanoparticle Treatment of Allergic Asthma
National Institutes of Health
Grant: 2T32HD007505-21
Training Program in Organogenesis
National Institutes of Health
Grant: 5R01NS080821-02
CD24 Targeting for Multiple Sclerosis: a First-In-Human Phase I Study
National Institutes of Health
Grant: 5R03AI105029-02
Enhancing Killer B Lymphocyte Function as a Treatment for Allergic Asthma
National Institutes of Health
Grant: 5UM1AI110557-05
University of Michigan Autoimmunity Center of Excellence, Clinical Research Progr
FWCI
2.70
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals